MarketCap
Hutchison China MediTech Limited HCM
$ 14.09
0.39%
Facebook
X
Telegram
Hutchison China MediTech Limited DIO Ratio | HCM
Annual DIO Ratio Hutchison China MediTech Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.7 | 52.7 | 50.8 | 54.2 | 111 | 103 | 113 | 124 | 181 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 181 | 49.7 | 93.2 |
Quarterly DIO Ratio Hutchison China MediTech Limited
| 2025-Q4 | 2025-Q2 | 2024-Q4 | 2024-Q2 | 2023-Q4 | 2023-Q2 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.2 | 26.9 | 12.7 | 120 | 12.4 | 54.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 121 | - | - | - | 68.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 121 | 12.2 | 53.4 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Фармсинтез
LIFE
|
120 | - | - | - |  Russia |
 |
Завод ДИОД
DIOD
|
768 | - | - | - | Russia |
 |
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B |  USA |
 |
Biofrontera AG
BFRA
|
482 | - | -8.24 % | $ 105 M |  Germany |
 |
China Biologic Products Holdings, Inc.
CBPO
|
530 | - | 1.68 % | $ 4.65 B |  China |
 |
Flexion Therapeutics, Inc.
FLXN
|
292 | - | - | $ 459 M | USA |
 |
Kindred Biosciences, Inc.
KIN
|
16.3 | - | 0.11 % | $ 419 M | USA |
 |
Shineco, Inc.
TYHT
|
37.4 | - | -3.90 % | $ 97.2 M | China |
 |
Progenity, Inc.
PROG
|
47.7 | - | -3.47 % | $ 164 M | USA |
 |
CTI BioPharma Corp.
CTIC
|
38.1 | - | - | $ 1.2 B | USA |
 |
Strongbridge Biopharma plc
SBBP
|
182 | - | 1.52 % | $ 136 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Affimed N.V.
AFMD
|
69.8 | - | -34.95 % | $ 21.5 M | Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
34.5 | - | -1.58 % | $ 28.1 M | China |
 |
Galapagos NV
GLPG
|
0.915 | - | - | $ 1.83 B |  Belgium |
 |
Teligent, Inc.
TLGT
|
198 | - | -13.85 % | $ 16.1 M | USA |
 |
Aphria Inc.
APHA
|
207 | - | -0.45 % | $ 4.87 B |  Canada |